The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of LDH and HCG levels in marker-positive seminomas.
 
Christoph Alexander Seidel
No Relationships to Disclose
 
Gedske Daugaard
No Relationships to Disclose
 
Tim Nestler
No Relationships to Disclose
 
Alexey Tryakin
Consulting or Advisory Role - BioCad; Bristol-Myers Squibb; Eisai; Roche/Genentech
Speakers' Bureau - Amgen; Bayer Health; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; Sanofi
Travel, Accommodations, Expenses - Bayer; BioCad; Novartis; Veropharm
 
Christian Daniel Fankhauser
No Relationships to Disclose
 
Thomas Hermanns
Consulting or Advisory Role - MSD
 
Jorge Aparicio
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi; SERVIER; Sirtex Medical
 
Julia Heinzelbecker
Honoraria - Pierre Fabre; Roche
Travel, Accommodations, Expenses - Ipsen
 
Pia Paffenholz
No Relationships to Disclose
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; Sanofi
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Roche
 
Richard Cathomas
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology; Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Anja Lorch
Honoraria - Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Ipsen; MSD Oncology
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Novartis
 
Felix Bremmer
No Relationships to Disclose
 
Patrizia Giannatempo
No Relationships to Disclose
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - AstraZeneca; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Gaetano Aurilio
No Relationships to Disclose
 
Chiara Casadei
No Relationships to Disclose
 
Christoph Oing
Honoraria - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; GSO; Hexal; Lilly/ImClone; Merck Serono; Merck Sharp & Dohme; Mundipharma; Sanofi
Research Funding - several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pfizer; Sanofi